Leukaemia Foundation policy submissions
The Leukaemia Foundation is actively involved in shaping policies that impact those affected by blood cancer
Here are some of our publicly available submissions and more will be uploaded as they become available. Please contact us if you have any questions regarding our submissions.
2024 – Leukaemia Foundation submissions
Public consultation on the refresh of the National Strategic Framework for Chronic Conditions Consultation – [PDF 468 KB] Draft National Optimal Care Pathways (OCP) Framework Survey – [PDF 216 KB] Co-design of an Enhanced Consumer Engagement Process for health technology assessment Consultation – [PDF 1.8 MB] Scope of Practice Review – Issues Paper 1 Public Submissions Survey – [PDF 512 KB] Health Technology Assessment Policy and Methods Review – Consultation 2 Consultation – [PDF 192 KB] Use of genetic testing in life insurance underwriting Consultation – [PDF 259 KB]2023 – Leukaemia Foundation submissions
Victorian Cancer Plan 2024-2028 Submission Survey – [PDF 257 KB] Unleashing the potential of our workforce – Scope of Practice Review Survey – [PDF 336 KB] Country SA PHN Health Access & Equity Framework Survey Submission Survey – [PDF 163 KB] South Australia Cancer Plan: Response to draft plan Survey – [PDF 185 KB] Inquiry into equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer Senate Inquiry – [PDF 7 MB] Aboriginal and Torres Strait Islander Cancer Plan Draft Consultation – [PDF 216 KB] Mid-Term Review of the National Health Reform Agreement (NHRA) Addendum 2020-2025 Consultation – [PDF 3 MB] HTA Review Consultation 1 Consultation – [PDF 3 MB] Inquiry into increasing the number of registered organ and tissue donors in Victoria Parliamentary Inquiry – [PDF 2 MB] Australia’s National Science and Research Priorities and National Science Statement Consultation – [PDF 2 MB] Inquiry into organ and tissue donation in Western Australia Parliamentary Inquiry – [PDF 944 KB] Strategic plan for the Nurse Practitioner workforce Consultation – [PDF 221 KB] Health Technology Assessment Review Terms of Reference Consultation Response Consultation – [PDF 221 KB]2022 – Leukaemia Foundation submissions
Leukaemia Foundation response to the Draft National Medicines Policy Consultation – [PDF 278 KB] Australian Cancer Plan consultation – vision survey Survey – [PDF 321 KB] Review of discount rate in the Pharmaceutical Benefits Advisory Committee Guidelines Consultation – [PDF 184 KB] NDIS General Issues Inquiry Parliamentary Inquiry – [PDF 231 KB] Leukaemia Foundation response to the updated Draft National Medicines Policy Consultation – [PDF 137 KB] Feedback on the Draft Australian Cancer Plan Consultation – [PDF 246 KB]2021 – Leukaemia Foundation submissions
Draft National Preventive Health Strategy Consultation Submission Consultation – [PDF 278 KB] Approval processes for new drugs and novel medical technologies in Australia Parliamentary Hearing – [PDF 195 KB] Response to NSW Cancer Plan Discussion Paper Consultation – [PDF 189 KB] Realising the rights and roles of Australian Cancer Patients Consultation – [PDF 151 KB] Consumer comments on the consultation survey for the EFC review on behalf of people living with blood cancer in Australia Consultation – [PDF 181 KB] Response to National Medicines Policy Review Consultation – [PDF 202 KB]2020 – Leukaemia Foundation submissions
Leukaemia Foundation comments on the Haematopoietic Progenitor Cell (HPC) Future Framework Consultation Paper Consultation – [PDF 207 KB] Response to Inquiry into approval processes for new drugs and novel medical technologies in Australia Parliamentary Inquiry – [PDF 302 KB]Last updated on June 4th, 2024
Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.